ApprovalTrail

Approval · Notice of Compliance 29174 · 2022

RACTOPAMINE 4: Notice of Compliance 29174

Issued October 12, 2022

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
29174
Date
October 12, 2022
Company
Bio Agri Mix LpMitchell, Ontario, Canada
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Addition of a drug subsatance manufacturing site, and change in drug product expiration period

Products in this notice

BrandDINStatus today
RACTOPAMINE 402472090Marketed

Medicinal ingredients